James Evans
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$3.5MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $3.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 27, 2021 | NIH | SBIR Phase II iPSC-Derived Neuronal Models of Alzheimer's Disease for Phenotypic Drug Screening | $634K | Phenovista Biosciences LLC |
| Feb 1, 2021 | NIH | SBIR Phase I Microglia models for Alzheimer's disease drug screening | $250K | Phenovista Biosciences LLC |
| Jan 19, 2021 | NIH | SBIR Phase I Microglia models for Alzheimer's disease drug screening | $250K | Phenovista Biosciences LLC |
| Aug 15, 2020 | NIH | SBIR Phase II iPSC-Derived Neuronal Models of Alzheimer's Disease for Phenotypic Drug Screening | $1.4M | Phenovista Biosciences LLC |
| Aug 10, 2020 | NIH | SBIR Phase II iPSC-Derived Neuronal Models of Alzheimer's Disease for Phenotypic Drug Screening | $790K | Phenovista Biosciences LLC |
| Sep 10, 2017 | NIH | SBIR Phase I iPSC-Derived Neuronal Models of Alzheimer's Disease for Drug Screening | $150K | Phenovista Biosciences LLC |
Peer ranks
Federal funding#493
Awards as PI#315
Patents#273
Companies
- Phenovista Biosciences LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.